Jupiter Topco LLC Acquires Shares of 15,913 Chemed Corporation $CHE

Jupiter Topco LLC bought a new position in shares of Chemed Corporation (NYSE:CHE) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 15,913 shares of the company’s stock, valued at approximately $7,412,000.

Several other hedge funds also recently made changes to their positions in CHE. Monetary Solutions Ltd acquired a new stake in shares of Chemed during the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed in the fourth quarter worth $26,000. BOK Financial Private Wealth Inc. acquired a new position in Chemed in the fourth quarter worth $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Chemed during the second quarter valued at $34,000. Finally, Versant Capital Management Inc increased its stake in Chemed by 7,500.0% during the second quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock valued at $35,000 after purchasing an additional 75 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the firm’s stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the sale, the director directly owned 3,533 shares in the company, valued at approximately $1,879,556. This trade represents a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 6,537 shares of company stock valued at $3,406,014. Company insiders own 3.33% of the company’s stock.

Chemed Price Performance

Shares of NYSE CHE opened at $523.57 on Monday. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The business’s fifty day moving average price is $509.45 and its two-hundred day moving average price is $449.68. The firm has a market capitalization of $6.84 billion, a PE ratio of 26.30, a P/E/G ratio of 1.98 and a beta of 0.51.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts expect that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a $0.70 dividend. The ex-dividend date is Monday, August 17th. This represents a $2.80 annualized dividend and a yield of 0.5%. This is a boost from Chemed’s previous quarterly dividend of $0.60. Chemed’s payout ratio is 14.06%.

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of recent research reports. Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research report on Friday, July 31st. Royal Bank Of Canada boosted their price objective on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research report on Thursday, July 30th. Bank of America reiterated a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Wall Street Zen raised shares of Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Finally, Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 17th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $530.75.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.